Medical Care
Medical Second Opinion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Apr 15, 24
- ID: 176693
- Pages: 129
- Figures: 198
- Views: 23
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
The global market for Medical Second Opinion was estimated to be worth US$ 4714 million in 2023 and is forecast to a readjusted size of US$ 19030 million by 2030 with a CAGR of 21.8% during the forecast period 2024-2030
The major players in global Medical Second Opinion market include HCA Hospitals, AXA PPP Healthcare, Royal London Group, etc. The top 3 players occupy about 20% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Hospitals is the main type, with a share about 45%. Cancer is the main application, which holds a share about 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Second Opinion, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Second Opinion by region & country, by Type, and by Application.
The Medical Second Opinion market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Second Opinion.
Market Segmentation
By Company
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.
Segment by Type:
Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies
Segment by Application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Second Opinion manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Second Opinion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Second Opinion in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Medical Second Opinion was estimated to be worth US$ 4714 million in 2023 and is forecast to a readjusted size of US$ 19030 million by 2030 with a CAGR of 21.8% during the forecast period 2024-2030
The major players in global Medical Second Opinion market include HCA Hospitals, AXA PPP Healthcare, Royal London Group, etc. The top 3 players occupy about 20% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Hospitals is the main type, with a share about 45%. Cancer is the main application, which holds a share about 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Second Opinion, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Second Opinion by region & country, by Type, and by Application.
The Medical Second Opinion market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Second Opinion.
Market Segmentation
By Company
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.
Segment by Type:
Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies
Segment by Application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Second Opinion manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Second Opinion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Second Opinion in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Medical Second Opinion Product Introduction
1.2 Global Medical Second Opinion Market Size Forecast
1.3 Medical Second Opinion Market Trends & Drivers
1.3.1 Medical Second Opinion Industry Trends
1.3.2 Medical Second Opinion Market Drivers & Opportunity
1.3.3 Medical Second Opinion Market Challenges
1.3.4 Medical Second Opinion Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Second Opinion Players Revenue Ranking (2023)
2.2 Global Medical Second Opinion Revenue by Company (2019-2024)
2.3 Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Second Opinion Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Second Opinion
2.6 Medical Second Opinion Market Competitive Analysis
2.6.1 Medical Second Opinion Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medical Second Opinion Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hospitals
3.1.2 Medical Second Opinion Providing Companies
3.1.3 Health Insurance Companies
3.2 Global Medical Second Opinion Sales Value by Type
3.2.1 Global Medical Second Opinion Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical Second Opinion Sales Value, by Type (2019-2030)
3.2.3 Global Medical Second Opinion Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Cardiac Disorders
4.1.4 Neurological Disorders
4.1.5 Ocular Disorders
4.1.6 Others
4.2 Global Medical Second Opinion Sales Value by Application
4.2.1 Global Medical Second Opinion Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical Second Opinion Sales Value, by Application (2019-2030)
4.2.3 Global Medical Second Opinion Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medical Second Opinion Sales Value by Region
5.1.1 Global Medical Second Opinion Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical Second Opinion Sales Value by Region (2019-2024)
5.1.3 Global Medical Second Opinion Sales Value by Region (2025-2030)
5.1.4 Global Medical Second Opinion Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medical Second Opinion Sales Value, 2019-2030
5.2.2 North America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medical Second Opinion Sales Value, 2019-2030
5.3.2 Europe Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Second Opinion Sales Value, 2019-2030
5.4.2 Asia Pacific Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medical Second Opinion Sales Value, 2019-2030
5.5.2 South America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Second Opinion Sales Value, 2019-2030
5.6.2 Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical Second Opinion Sales Value
6.3 United States
6.3.1 United States Medical Second Opinion Sales Value, 2019-2030
6.3.2 United States Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical Second Opinion Sales Value, 2019-2030
6.4.2 Europe Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical Second Opinion Sales Value, 2019-2030
6.5.2 China Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical Second Opinion Sales Value, 2019-2030
6.6.2 Japan Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical Second Opinion Sales Value, 2019-2030
6.7.2 South Korea Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Second Opinion Sales Value, 2019-2030
6.8.2 Southeast Asia Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical Second Opinion Sales Value, 2019-2030
6.9.2 India Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical Second Opinion Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 HCA Hospitals
7.1.1 HCA Hospitals Profile
7.1.2 HCA Hospitals Main Business
7.1.3 HCA Hospitals Medical Second Opinion Products, Services and Solutions
7.1.4 HCA Hospitals Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.1.5 HCA Hospitals Recent Developments
7.2 AXA PPP Healthcare
7.2.1 AXA PPP Healthcare Profile
7.2.2 AXA PPP Healthcare Main Business
7.2.3 AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
7.2.4 AXA PPP Healthcare Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.2.5 AXA PPP Healthcare Recent Developments
7.3 Royal London Group
7.3.1 Royal London Group Profile
7.3.2 Royal London Group Main Business
7.3.3 Royal London Group Medical Second Opinion Products, Services and Solutions
7.3.4 Royal London Group Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.3.5 Helsana Group Recent Developments
7.4 Helsana Group
7.4.1 Helsana Group Profile
7.4.2 Helsana Group Main Business
7.4.3 Helsana Group Medical Second Opinion Products, Services and Solutions
7.4.4 Helsana Group Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.4.5 Helsana Group Recent Developments
7.5 Cleveland Clinic
7.5.1 Cleveland Clinic Profile
7.5.2 Cleveland Clinic Main Business
7.5.3 Cleveland Clinic Medical Second Opinion Products, Services and Solutions
7.5.4 Cleveland Clinic Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.5.5 Cleveland Clinic Recent Developments
7.6 Amradnet
7.6.1 Amradnet Profile
7.6.2 Amradnet Main Business
7.6.3 Amradnet Medical Second Opinion Products, Services and Solutions
7.6.4 Amradnet Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.6.5 Amradnet Recent Developments
7.7 Best Doctors Inc
7.7.1 Best Doctors Inc Profile
7.7.2 Best Doctors Inc Main Business
7.7.3 Best Doctors Inc Medical Second Opinion Products, Services and Solutions
7.7.4 Best Doctors Inc Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.7.5 Best Doctors Inc Recent Developments
7.8 Inova Care
7.8.1 Inova Care Profile
7.8.2 Inova Care Main Business
7.8.3 Inova Care Medical Second Opinion Products, Services and Solutions
7.8.4 Inova Care Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.8.5 Inova Care Recent Developments
7.9 Toranomon Hospital
7.9.1 Toranomon Hospital Profile
7.9.2 Toranomon Hospital Main Business
7.9.3 Toranomon Hospital Medical Second Opinion Products, Services and Solutions
7.9.4 Toranomon Hospital Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.9.5 Toranomon Hospital Recent Developments
7.10 Keio University Hospital
7.10.1 Keio University Hospital Profile
7.10.2 Keio University Hospital Main Business
7.10.3 Keio University Hospital Medical Second Opinion Products, Services and Solutions
7.10.4 Keio University Hospital Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.10.5 Keio University Hospital Recent Developments
7.11 Johns Hopkins Medicine
7.11.1 Johns Hopkins Medicine Profile
7.11.2 Johns Hopkins Medicine Main Business
7.11.3 Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
7.11.4 Johns Hopkins Medicine Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.11.5 Johns Hopkins Medicine Recent Developments
7.12 Penn Medicine
7.12.1 Penn Medicine Profile
7.12.2 Penn Medicine Main Business
7.12.3 Penn Medicine Medical Second Opinion Products, Services and Solutions
7.12.4 Penn Medicine Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.12.5 Penn Medicine Recent Developments
7.13 Oncology International Pvt. Ltd.
7.13.1 Oncology International Pvt. Ltd. Profile
7.13.2 Oncology International Pvt. Ltd. Main Business
7.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
7.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.13.5 Oncology International Pvt. Ltd. Recent Developments
7.14 GrandOpinion
7.14.1 GrandOpinion Profile
7.14.2 GrandOpinion Main Business
7.14.3 GrandOpinion Medical Second Opinion Products, Services and Solutions
7.14.4 GrandOpinion Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.14.5 GrandOpinion Recent Developments
7.15 London Pain Clinic
7.15.1 London Pain Clinic Profile
7.15.2 London Pain Clinic Main Business
7.15.3 London Pain Clinic Medical Second Opinion Products, Services and Solutions
7.15.4 London Pain Clinic Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.15.5 London Pain Clinic Recent Developments
7.16 Mondial Assistance
7.16.1 Mondial Assistance Profile
7.16.2 Mondial Assistance Main Business
7.16.3 Mondial Assistance Medical Second Opinion Products, Services and Solutions
7.16.4 Mondial Assistance Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.16.5 Mondial Assistance Recent Developments
7.17 Medisense
7.17.1 Medisense Profile
7.17.2 Medisense Main Business
7.17.3 Medisense Medical Second Opinion Products, Services and Solutions
7.17.4 Medisense Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.17.5 Medisense Recent Developments
7.18 Medo Asia Sdn. Bhd.
7.18.1 Medo Asia Sdn. Bhd. Profile
7.18.2 Medo Asia Sdn. Bhd. Main Business
7.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
7.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.18.5 Medo Asia Sdn. Bhd. Recent Developments
8 Industry Chain Analysis
8.1 Medical Second Opinion Industrial Chain
8.2 Medical Second Opinion Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Second Opinion Sales Model
8.5.2 Sales Channel
8.5.3 Medical Second Opinion Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Medical Second Opinion Product Introduction
1.2 Global Medical Second Opinion Market Size Forecast
1.3 Medical Second Opinion Market Trends & Drivers
1.3.1 Medical Second Opinion Industry Trends
1.3.2 Medical Second Opinion Market Drivers & Opportunity
1.3.3 Medical Second Opinion Market Challenges
1.3.4 Medical Second Opinion Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Second Opinion Players Revenue Ranking (2023)
2.2 Global Medical Second Opinion Revenue by Company (2019-2024)
2.3 Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Second Opinion Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Second Opinion
2.6 Medical Second Opinion Market Competitive Analysis
2.6.1 Medical Second Opinion Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medical Second Opinion Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hospitals
3.1.2 Medical Second Opinion Providing Companies
3.1.3 Health Insurance Companies
3.2 Global Medical Second Opinion Sales Value by Type
3.2.1 Global Medical Second Opinion Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical Second Opinion Sales Value, by Type (2019-2030)
3.2.3 Global Medical Second Opinion Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Diabetes
4.1.3 Cardiac Disorders
4.1.4 Neurological Disorders
4.1.5 Ocular Disorders
4.1.6 Others
4.2 Global Medical Second Opinion Sales Value by Application
4.2.1 Global Medical Second Opinion Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical Second Opinion Sales Value, by Application (2019-2030)
4.2.3 Global Medical Second Opinion Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medical Second Opinion Sales Value by Region
5.1.1 Global Medical Second Opinion Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical Second Opinion Sales Value by Region (2019-2024)
5.1.3 Global Medical Second Opinion Sales Value by Region (2025-2030)
5.1.4 Global Medical Second Opinion Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medical Second Opinion Sales Value, 2019-2030
5.2.2 North America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medical Second Opinion Sales Value, 2019-2030
5.3.2 Europe Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Second Opinion Sales Value, 2019-2030
5.4.2 Asia Pacific Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medical Second Opinion Sales Value, 2019-2030
5.5.2 South America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Second Opinion Sales Value, 2019-2030
5.6.2 Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical Second Opinion Sales Value
6.3 United States
6.3.1 United States Medical Second Opinion Sales Value, 2019-2030
6.3.2 United States Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical Second Opinion Sales Value, 2019-2030
6.4.2 Europe Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical Second Opinion Sales Value, 2019-2030
6.5.2 China Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical Second Opinion Sales Value, 2019-2030
6.6.2 Japan Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical Second Opinion Sales Value, 2019-2030
6.7.2 South Korea Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Second Opinion Sales Value, 2019-2030
6.8.2 Southeast Asia Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical Second Opinion Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical Second Opinion Sales Value, 2019-2030
6.9.2 India Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical Second Opinion Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 HCA Hospitals
7.1.1 HCA Hospitals Profile
7.1.2 HCA Hospitals Main Business
7.1.3 HCA Hospitals Medical Second Opinion Products, Services and Solutions
7.1.4 HCA Hospitals Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.1.5 HCA Hospitals Recent Developments
7.2 AXA PPP Healthcare
7.2.1 AXA PPP Healthcare Profile
7.2.2 AXA PPP Healthcare Main Business
7.2.3 AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
7.2.4 AXA PPP Healthcare Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.2.5 AXA PPP Healthcare Recent Developments
7.3 Royal London Group
7.3.1 Royal London Group Profile
7.3.2 Royal London Group Main Business
7.3.3 Royal London Group Medical Second Opinion Products, Services and Solutions
7.3.4 Royal London Group Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.3.5 Helsana Group Recent Developments
7.4 Helsana Group
7.4.1 Helsana Group Profile
7.4.2 Helsana Group Main Business
7.4.3 Helsana Group Medical Second Opinion Products, Services and Solutions
7.4.4 Helsana Group Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.4.5 Helsana Group Recent Developments
7.5 Cleveland Clinic
7.5.1 Cleveland Clinic Profile
7.5.2 Cleveland Clinic Main Business
7.5.3 Cleveland Clinic Medical Second Opinion Products, Services and Solutions
7.5.4 Cleveland Clinic Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.5.5 Cleveland Clinic Recent Developments
7.6 Amradnet
7.6.1 Amradnet Profile
7.6.2 Amradnet Main Business
7.6.3 Amradnet Medical Second Opinion Products, Services and Solutions
7.6.4 Amradnet Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.6.5 Amradnet Recent Developments
7.7 Best Doctors Inc
7.7.1 Best Doctors Inc Profile
7.7.2 Best Doctors Inc Main Business
7.7.3 Best Doctors Inc Medical Second Opinion Products, Services and Solutions
7.7.4 Best Doctors Inc Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.7.5 Best Doctors Inc Recent Developments
7.8 Inova Care
7.8.1 Inova Care Profile
7.8.2 Inova Care Main Business
7.8.3 Inova Care Medical Second Opinion Products, Services and Solutions
7.8.4 Inova Care Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.8.5 Inova Care Recent Developments
7.9 Toranomon Hospital
7.9.1 Toranomon Hospital Profile
7.9.2 Toranomon Hospital Main Business
7.9.3 Toranomon Hospital Medical Second Opinion Products, Services and Solutions
7.9.4 Toranomon Hospital Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.9.5 Toranomon Hospital Recent Developments
7.10 Keio University Hospital
7.10.1 Keio University Hospital Profile
7.10.2 Keio University Hospital Main Business
7.10.3 Keio University Hospital Medical Second Opinion Products, Services and Solutions
7.10.4 Keio University Hospital Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.10.5 Keio University Hospital Recent Developments
7.11 Johns Hopkins Medicine
7.11.1 Johns Hopkins Medicine Profile
7.11.2 Johns Hopkins Medicine Main Business
7.11.3 Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
7.11.4 Johns Hopkins Medicine Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.11.5 Johns Hopkins Medicine Recent Developments
7.12 Penn Medicine
7.12.1 Penn Medicine Profile
7.12.2 Penn Medicine Main Business
7.12.3 Penn Medicine Medical Second Opinion Products, Services and Solutions
7.12.4 Penn Medicine Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.12.5 Penn Medicine Recent Developments
7.13 Oncology International Pvt. Ltd.
7.13.1 Oncology International Pvt. Ltd. Profile
7.13.2 Oncology International Pvt. Ltd. Main Business
7.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
7.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.13.5 Oncology International Pvt. Ltd. Recent Developments
7.14 GrandOpinion
7.14.1 GrandOpinion Profile
7.14.2 GrandOpinion Main Business
7.14.3 GrandOpinion Medical Second Opinion Products, Services and Solutions
7.14.4 GrandOpinion Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.14.5 GrandOpinion Recent Developments
7.15 London Pain Clinic
7.15.1 London Pain Clinic Profile
7.15.2 London Pain Clinic Main Business
7.15.3 London Pain Clinic Medical Second Opinion Products, Services and Solutions
7.15.4 London Pain Clinic Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.15.5 London Pain Clinic Recent Developments
7.16 Mondial Assistance
7.16.1 Mondial Assistance Profile
7.16.2 Mondial Assistance Main Business
7.16.3 Mondial Assistance Medical Second Opinion Products, Services and Solutions
7.16.4 Mondial Assistance Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.16.5 Mondial Assistance Recent Developments
7.17 Medisense
7.17.1 Medisense Profile
7.17.2 Medisense Main Business
7.17.3 Medisense Medical Second Opinion Products, Services and Solutions
7.17.4 Medisense Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.17.5 Medisense Recent Developments
7.18 Medo Asia Sdn. Bhd.
7.18.1 Medo Asia Sdn. Bhd. Profile
7.18.2 Medo Asia Sdn. Bhd. Main Business
7.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
7.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue (US$ Million) & (2019-2024)
7.18.5 Medo Asia Sdn. Bhd. Recent Developments
8 Industry Chain Analysis
8.1 Medical Second Opinion Industrial Chain
8.2 Medical Second Opinion Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Second Opinion Sales Model
8.5.2 Sales Channel
8.5.3 Medical Second Opinion Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Medical Second Opinion Market Trends
Table 2. Medical Second Opinion Market Drivers & Opportunity
Table 3. Medical Second Opinion Market Challenges
Table 4. Medical Second Opinion Market Restraints
Table 5. Global Medical Second Opinion Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Medical Second Opinion Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Medical Second Opinion Product Type
Table 9. Key Companies Time to Begin Mass Production of Medical Second Opinion
Table 10. Global Medical Second Opinion Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Medical Second Opinion Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Medical Second Opinion Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Medical Second Opinion Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Medical Second Opinion Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Medical Second Opinion Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Medical Second Opinion Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Medical Second Opinion Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Medical Second Opinion Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Medical Second Opinion Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Medical Second Opinion Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Medical Second Opinion Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Medical Second Opinion Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Medical Second Opinion Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Medical Second Opinion Sales Value by Region (2019-2024) & (%)
Table 27. Global Medical Second Opinion Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Medical Second Opinion Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Medical Second Opinion Sales Value, (2025-2030) & (US$ Million)
Table 31. HCA Hospitals Basic Information List
Table 32. HCA Hospitals Description and Business Overview
Table 33. HCA Hospitals Medical Second Opinion Products, Services and Solutions
Table 34. Revenue (US$ Million) in Medical Second Opinion Business of HCA Hospitals (2019-2024)
Table 35. HCA Hospitals Recent Developments
Table 36. AXA PPP Healthcare Basic Information List
Table 37. AXA PPP Healthcare Description and Business Overview
Table 38. AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
Table 39. Revenue (US$ Million) in Medical Second Opinion Business of AXA PPP Healthcare (2019-2024)
Table 40. AXA PPP Healthcare Recent Developments
Table 41. Royal London Group Basic Information List
Table 42. Royal London Group Description and Business Overview
Table 43. Royal London Group Medical Second Opinion Products, Services and Solutions
Table 44. Revenue (US$ Million) in Medical Second Opinion Business of Royal London Group (2019-2024)
Table 45. Royal London Group Recent Developments
Table 46. Helsana Group Basic Information List
Table 47. Helsana Group Description and Business Overview
Table 48. Helsana Group Medical Second Opinion Products, Services and Solutions
Table 49. Revenue (US$ Million) in Medical Second Opinion Business of Helsana Group (2019-2024)
Table 50. Helsana Group Recent Developments
Table 51. Cleveland Clinic Basic Information List
Table 52. Cleveland Clinic Description and Business Overview
Table 53. Cleveland Clinic Medical Second Opinion Products, Services and Solutions
Table 54. Revenue (US$ Million) in Medical Second Opinion Business of Cleveland Clinic (2019-2024)
Table 55. Cleveland Clinic Recent Developments
Table 56. Amradnet Basic Information List
Table 57. Amradnet Description and Business Overview
Table 58. Amradnet Medical Second Opinion Products, Services and Solutions
Table 59. Revenue (US$ Million) in Medical Second Opinion Business of Amradnet (2019-2024)
Table 60. Amradnet Recent Developments
Table 61. Best Doctors Inc Basic Information List
Table 62. Best Doctors Inc Description and Business Overview
Table 63. Best Doctors Inc Medical Second Opinion Products, Services and Solutions
Table 64. Revenue (US$ Million) in Medical Second Opinion Business of Best Doctors Inc (2019-2024)
Table 65. Best Doctors Inc Recent Developments
Table 66. Inova Care Basic Information List
Table 67. Inova Care Description and Business Overview
Table 68. Inova Care Medical Second Opinion Products, Services and Solutions
Table 69. Revenue (US$ Million) in Medical Second Opinion Business of Inova Care (2019-2024)
Table 70. Inova Care Recent Developments
Table 71. Toranomon Hospital Basic Information List
Table 72. Toranomon Hospital Description and Business Overview
Table 73. Toranomon Hospital Medical Second Opinion Products, Services and Solutions
Table 74. Revenue (US$ Million) in Medical Second Opinion Business of Toranomon Hospital (2019-2024)
Table 75. Toranomon Hospital Recent Developments
Table 76. Keio University Hospital Basic Information List
Table 77. Keio University Hospital Description and Business Overview
Table 78. Keio University Hospital Medical Second Opinion Products, Services and Solutions
Table 79. Revenue (US$ Million) in Medical Second Opinion Business of Keio University Hospital (2019-2024)
Table 80. Keio University Hospital Recent Developments
Table 81. Johns Hopkins Medicine Basic Information List
Table 82. Johns Hopkins Medicine Description and Business Overview
Table 83. Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
Table 84. Revenue (US$ Million) in Medical Second Opinion Business of Johns Hopkins Medicine (2019-2024)
Table 85. Johns Hopkins Medicine Recent Developments
Table 86. Penn Medicine Basic Information List
Table 87. Penn Medicine Description and Business Overview
Table 88. Penn Medicine Medical Second Opinion Products, Services and Solutions
Table 89. Revenue (US$ Million) in Medical Second Opinion Business of Penn Medicine (2019-2024)
Table 90. Penn Medicine Recent Developments
Table 91. Oncology International Pvt. Ltd. Basic Information List
Table 92. Oncology International Pvt. Ltd. Description and Business Overview
Table 93. Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
Table 94. Revenue (US$ Million) in Medical Second Opinion Business of Oncology International Pvt. Ltd. (2019-2024)
Table 95. Oncology International Pvt. Ltd. Recent Developments
Table 96. GrandOpinion Basic Information List
Table 97. GrandOpinion Description and Business Overview
Table 98. GrandOpinion Medical Second Opinion Products, Services and Solutions
Table 99. Revenue (US$ Million) in Medical Second Opinion Business of GrandOpinion (2019-2024)
Table 100. GrandOpinion Recent Developments
Table 101. London Pain Clinic Basic Information List
Table 102. London Pain Clinic Description and Business Overview
Table 103. London Pain Clinic Medical Second Opinion Products, Services and Solutions
Table 104. Revenue (US$ Million) in Medical Second Opinion Business of London Pain Clinic (2019-2024)
Table 105. London Pain Clinic Recent Developments
Table 106. Mondial Assistance Basic Information List
Table 107. Mondial Assistance Description and Business Overview
Table 108. Mondial Assistance Medical Second Opinion Products, Services and Solutions
Table 109. Revenue (US$ Million) in Medical Second Opinion Business of Mondial Assistance (2019-2024)
Table 110. Mondial Assistance Recent Developments
Table 111. Medisense Basic Information List
Table 112. Medisense Description and Business Overview
Table 113. Medisense Medical Second Opinion Products, Services and Solutions
Table 114. Revenue (US$ Million) in Medical Second Opinion Business of Medisense (2019-2024)
Table 115. Medisense Recent Developments
Table 116. Medo Asia Sdn. Bhd. Basic Information List
Table 117. Medo Asia Sdn. Bhd. Description and Business Overview
Table 118. Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
Table 119. Revenue (US$ Million) in Medical Second Opinion Business of Medo Asia Sdn. Bhd. (2019-2024)
Table 120. Medo Asia Sdn. Bhd. Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Medical Second Opinion Downstream Customers
Table 124. Medical Second Opinion Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Medical Second Opinion Product Picture
Figure 2. Global Medical Second Opinion Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 4. Medical Second Opinion Report Years Considered
Figure 5. Global Medical Second Opinion Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Second Opinion Revenue in 2023
Figure 7. Medical Second Opinion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Hospitals Picture
Figure 9. Medical Second Opinion Providing Companies Picture
Figure 10. Health Insurance Companies Picture
Figure 11. Global Medical Second Opinion Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Medical Second Opinion Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Cancer
Figure 14. Product Picture of Diabetes
Figure 15. Product Picture of Cardiac Disorders
Figure 16. Product Picture of Neurological Disorders
Figure 17. Product Picture of Ocular Disorders
Figure 18. Product Picture of Others
Figure 19. Global Medical Second Opinion Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Medical Second Opinion Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Medical Second Opinion Sales Value (%), (2019-2030)
Figure 32. United States Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 38. China Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 40. China Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 50. India Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 52. India Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 53. Medical Second Opinion Industrial Chain
Figure 54. Medical Second Opinion Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Table 1. Medical Second Opinion Market Trends
Table 2. Medical Second Opinion Market Drivers & Opportunity
Table 3. Medical Second Opinion Market Challenges
Table 4. Medical Second Opinion Market Restraints
Table 5. Global Medical Second Opinion Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Medical Second Opinion Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Medical Second Opinion Product Type
Table 9. Key Companies Time to Begin Mass Production of Medical Second Opinion
Table 10. Global Medical Second Opinion Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Medical Second Opinion Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Medical Second Opinion Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Medical Second Opinion Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Medical Second Opinion Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Medical Second Opinion Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Medical Second Opinion Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Medical Second Opinion Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Medical Second Opinion Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Medical Second Opinion Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Medical Second Opinion Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Medical Second Opinion Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Medical Second Opinion Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Medical Second Opinion Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Medical Second Opinion Sales Value by Region (2019-2024) & (%)
Table 27. Global Medical Second Opinion Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Medical Second Opinion Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Medical Second Opinion Sales Value, (2025-2030) & (US$ Million)
Table 31. HCA Hospitals Basic Information List
Table 32. HCA Hospitals Description and Business Overview
Table 33. HCA Hospitals Medical Second Opinion Products, Services and Solutions
Table 34. Revenue (US$ Million) in Medical Second Opinion Business of HCA Hospitals (2019-2024)
Table 35. HCA Hospitals Recent Developments
Table 36. AXA PPP Healthcare Basic Information List
Table 37. AXA PPP Healthcare Description and Business Overview
Table 38. AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
Table 39. Revenue (US$ Million) in Medical Second Opinion Business of AXA PPP Healthcare (2019-2024)
Table 40. AXA PPP Healthcare Recent Developments
Table 41. Royal London Group Basic Information List
Table 42. Royal London Group Description and Business Overview
Table 43. Royal London Group Medical Second Opinion Products, Services and Solutions
Table 44. Revenue (US$ Million) in Medical Second Opinion Business of Royal London Group (2019-2024)
Table 45. Royal London Group Recent Developments
Table 46. Helsana Group Basic Information List
Table 47. Helsana Group Description and Business Overview
Table 48. Helsana Group Medical Second Opinion Products, Services and Solutions
Table 49. Revenue (US$ Million) in Medical Second Opinion Business of Helsana Group (2019-2024)
Table 50. Helsana Group Recent Developments
Table 51. Cleveland Clinic Basic Information List
Table 52. Cleveland Clinic Description and Business Overview
Table 53. Cleveland Clinic Medical Second Opinion Products, Services and Solutions
Table 54. Revenue (US$ Million) in Medical Second Opinion Business of Cleveland Clinic (2019-2024)
Table 55. Cleveland Clinic Recent Developments
Table 56. Amradnet Basic Information List
Table 57. Amradnet Description and Business Overview
Table 58. Amradnet Medical Second Opinion Products, Services and Solutions
Table 59. Revenue (US$ Million) in Medical Second Opinion Business of Amradnet (2019-2024)
Table 60. Amradnet Recent Developments
Table 61. Best Doctors Inc Basic Information List
Table 62. Best Doctors Inc Description and Business Overview
Table 63. Best Doctors Inc Medical Second Opinion Products, Services and Solutions
Table 64. Revenue (US$ Million) in Medical Second Opinion Business of Best Doctors Inc (2019-2024)
Table 65. Best Doctors Inc Recent Developments
Table 66. Inova Care Basic Information List
Table 67. Inova Care Description and Business Overview
Table 68. Inova Care Medical Second Opinion Products, Services and Solutions
Table 69. Revenue (US$ Million) in Medical Second Opinion Business of Inova Care (2019-2024)
Table 70. Inova Care Recent Developments
Table 71. Toranomon Hospital Basic Information List
Table 72. Toranomon Hospital Description and Business Overview
Table 73. Toranomon Hospital Medical Second Opinion Products, Services and Solutions
Table 74. Revenue (US$ Million) in Medical Second Opinion Business of Toranomon Hospital (2019-2024)
Table 75. Toranomon Hospital Recent Developments
Table 76. Keio University Hospital Basic Information List
Table 77. Keio University Hospital Description and Business Overview
Table 78. Keio University Hospital Medical Second Opinion Products, Services and Solutions
Table 79. Revenue (US$ Million) in Medical Second Opinion Business of Keio University Hospital (2019-2024)
Table 80. Keio University Hospital Recent Developments
Table 81. Johns Hopkins Medicine Basic Information List
Table 82. Johns Hopkins Medicine Description and Business Overview
Table 83. Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
Table 84. Revenue (US$ Million) in Medical Second Opinion Business of Johns Hopkins Medicine (2019-2024)
Table 85. Johns Hopkins Medicine Recent Developments
Table 86. Penn Medicine Basic Information List
Table 87. Penn Medicine Description and Business Overview
Table 88. Penn Medicine Medical Second Opinion Products, Services and Solutions
Table 89. Revenue (US$ Million) in Medical Second Opinion Business of Penn Medicine (2019-2024)
Table 90. Penn Medicine Recent Developments
Table 91. Oncology International Pvt. Ltd. Basic Information List
Table 92. Oncology International Pvt. Ltd. Description and Business Overview
Table 93. Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
Table 94. Revenue (US$ Million) in Medical Second Opinion Business of Oncology International Pvt. Ltd. (2019-2024)
Table 95. Oncology International Pvt. Ltd. Recent Developments
Table 96. GrandOpinion Basic Information List
Table 97. GrandOpinion Description and Business Overview
Table 98. GrandOpinion Medical Second Opinion Products, Services and Solutions
Table 99. Revenue (US$ Million) in Medical Second Opinion Business of GrandOpinion (2019-2024)
Table 100. GrandOpinion Recent Developments
Table 101. London Pain Clinic Basic Information List
Table 102. London Pain Clinic Description and Business Overview
Table 103. London Pain Clinic Medical Second Opinion Products, Services and Solutions
Table 104. Revenue (US$ Million) in Medical Second Opinion Business of London Pain Clinic (2019-2024)
Table 105. London Pain Clinic Recent Developments
Table 106. Mondial Assistance Basic Information List
Table 107. Mondial Assistance Description and Business Overview
Table 108. Mondial Assistance Medical Second Opinion Products, Services and Solutions
Table 109. Revenue (US$ Million) in Medical Second Opinion Business of Mondial Assistance (2019-2024)
Table 110. Mondial Assistance Recent Developments
Table 111. Medisense Basic Information List
Table 112. Medisense Description and Business Overview
Table 113. Medisense Medical Second Opinion Products, Services and Solutions
Table 114. Revenue (US$ Million) in Medical Second Opinion Business of Medisense (2019-2024)
Table 115. Medisense Recent Developments
Table 116. Medo Asia Sdn. Bhd. Basic Information List
Table 117. Medo Asia Sdn. Bhd. Description and Business Overview
Table 118. Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
Table 119. Revenue (US$ Million) in Medical Second Opinion Business of Medo Asia Sdn. Bhd. (2019-2024)
Table 120. Medo Asia Sdn. Bhd. Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Medical Second Opinion Downstream Customers
Table 124. Medical Second Opinion Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Medical Second Opinion Product Picture
Figure 2. Global Medical Second Opinion Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 4. Medical Second Opinion Report Years Considered
Figure 5. Global Medical Second Opinion Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Second Opinion Revenue in 2023
Figure 7. Medical Second Opinion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Hospitals Picture
Figure 9. Medical Second Opinion Providing Companies Picture
Figure 10. Health Insurance Companies Picture
Figure 11. Global Medical Second Opinion Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Medical Second Opinion Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Cancer
Figure 14. Product Picture of Diabetes
Figure 15. Product Picture of Cardiac Disorders
Figure 16. Product Picture of Neurological Disorders
Figure 17. Product Picture of Ocular Disorders
Figure 18. Product Picture of Others
Figure 19. Global Medical Second Opinion Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Medical Second Opinion Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Medical Second Opinion Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Medical Second Opinion Sales Value (%), (2019-2030)
Figure 32. United States Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 38. China Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 40. China Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 50. India Medical Second Opinion Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Medical Second Opinion Sales Value by Type (%), 2023 VS 2030
Figure 52. India Medical Second Opinion Sales Value by Application (%), 2023 VS 2030
Figure 53. Medical Second Opinion Industrial Chain
Figure 54. Medical Second Opinion Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232